Your shopping cart is currently empty

PC786 is a potent and selective non-nucleoside RSV L-protein polymerase inhibitor for inhalation therapy of RSV infections, with antiviral activity against RSV-A (IC50=0.09-0.71 nM) and RSV-B (IC 50=1.3-50.6 nM), and the ability to inhibit RSV RNA-dependent RNA polymerase in HEp-2 cells ( RdRp).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $399 | - | In Stock |
| Description | PC786 is a potent and selective non-nucleoside RSV L-protein polymerase inhibitor for inhalation therapy of RSV infections, with antiviral activity against RSV-A (IC50=0.09-0.71 nM) and RSV-B (IC 50=1.3-50.6 nM), and the ability to inhibit RSV RNA-dependent RNA polymerase in HEp-2 cells ( RdRp). |
| Targets&IC50 | RSV B:1.3–50.6 nM, RSV A:<0.09–0.71 nM, RdRp (RSV, cell-free enzyme assay):14.11 μM, RdRp (RSV, minigenome assay in HEp-2 cells):0.5 nM |
| In vitro | PC786 exhibits strong antiviral activity against RSV-A (IC₅₀: <0.09–0.71 nM) and RSV-B (IC₅₀: 1.3–50.6 nM) in HEp-2 cells, with no detectable cytotoxicity.[1] PCR analysis confirmed inhibition of RSV replication, and PC786 potently inhibited RSV RNA-dependent RNA polymerase (RdRp) activity in both a cell-free enzyme assay (IC₅₀: 2.1 nM) and a minigenome assay in HEp-2 cells (IC₅₀: 0.5 nM).[1] |
| In vivo | Treatment with PC786 (either intratracheal or intranasal; Once-daily on days-1 to 3), is found to inhibit viral loads in the lungs of RSV A2-infected BALB/c mice. The viral load is below the level of detection when the drug is given at 2 mg/mL (40 μg/mouse [approximately 1.6 mg/kg of body weight] for i.t. treatment, or 80 μg/mouse [approximately 3.2 mg/kg] for i.n. treatment)[1]. |
| Synonyms | PC 786 |
| Molecular Weight | 715.84 |
| Formula | C41H38FN5O4S |
| Cas No. | 1902114-15-1 |
| Smiles | O=C(NC=1C(F)=CC=CC1C)C=2SC=3C=4C=CC=CC4N(C(=O)C5=CC=C(C=C5)NC(=O)C6=CC(=CN=C6N7CC8(C7)CCOCC8)C)CCC3C2 |
| Relative Density. | 1.41 g/cm3 (Predicted) |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 120 mg/mL (167.64 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 4 mg/mL (5.59 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.